Indian manufacture of new generic antiretrovirals: implications for global access to anti-HIV drugs
Venkatesh, K K; Kumarasamy, N; Mayer, K H
HIV Therapy 4(1): 1-4
2010
ISSN/ISBN: 1758-4310 DOI: 10.2217/hiv.09.55Document Number: 253475
Document emailed within 0-6 h
Related Documents
Beck, E.J.; Passarelli, C.; Lui, I.; Guichard, A.-C.; Simao, M.; De Lay, P.; Loures, L. 2014: Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health Antiviral Therapy 19(Suppl 3): 117-123Beck, E.J.; Passarelli, C.; Lui, I.; Guichard, A.-C.; Simao, M.; De Lay, P.; Loures, L. 2014: Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health Antiviral Therapy 19(Suppl 3): 117-123
Zarocostas, J. 2011: Poor countries should use flexibility in global trade agreement to improve access to antiretrovirals, says report Bmj 342: D1677
Chu, S.K.H. 2011: Proposed EU-India free trade agreement could impede manufacture of generic HIV drugs Hiv/Aids Policy and Law Review 15(2): 22-23
Elliott, R. 2002: Global fund decides to promote use of generic drugs Canadian Hiv/Aids Policy and Law Review 7(2-3): 58-59
Biraben, A.; De-Toffol, B.; Semah, F.; Rouaud, T. 2007: Use of generic anti-epilepsy drugs in France: survey of neurologists and review of the literature Revue Neurologique (Paris) 163(4): 455-461
de Silva, T.; Weiss, R.A. 2010: HIV-2 goes global: an unaddressed issue in Indian anti-retroviral programmes Indian Journal of Medical Research 132: 660-662
Babovic, S.; Wasan, K.M. 2011: Impact of the trade-related aspects of intellectual property rights (TRIPS) agreement on India as a supplier of generic antiretrovirals Journal of Pharmaceutical Sciences 100(3): 816-821
Mileshkin, L.; Sullivan, D. 2011: Access to expensive anti-cancer drugs Journal of Law and Medicine 19(2): 232-243
2001: Access to antiretrovirals in South Africa Reproductive health matters 9(18): 180
Galvão, J. 2004: Access to antiretrovirals: where South Africa, China, and Brazil meet Lancet 363(9407): 493
Gray, A.; Conradie, F.; Crowley, T.; Gaede, B.; Gils, T.; Shroufi, A.; Hwang, B.; Kegakilwe, D.; Nash, J.; Pillay, P.; Stende, S.C.; Venter, F.; Matthews, P. 2015: Improving access to antiretrovirals in rural South Africa - a call to action South African Medical Journal 105(8): 638-640
Gupta, R.K.; Wainberg, M.A.; Brun-Vezinet, F.; Gatell, J.M.; Albert, J.; Sönnerborg, A.; Nachega, J.B. 2013: Oral antiretroviral drugs as public health tools for HIV prevention: global implications for adherence, drug resistance, and the success of HIV treatment programs Journal of Infectious Diseases 207 Suppl. 2: S101-S106
Bangalee, V; Suleman, F 2016: Has the increase in the availability of generic drugs lowered the price of cardiovascular drugs in South Africa? Health Sa Gesondheid 21: 60-66
Bhatt, C.B.; Pipalia, D.H.; Naik, S.R.; Tilve, G.H. 1988: Efficacy of misoprostol in upper gastro-intestinal lesions in arthritic patients on non-steroidal anti-inflammatory drugs (NSAIDS)--an Indian experience Journal of Postgraduate Medicine 34(4): 224-228
Singh S; Kumar, J.; Singh, R.; Dwivedi, S.N. 2000: Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 4(4): 203-208
Moutel, G.; Hervé, C. 2001: Access to care, access to rights, and health education: stakes of the global management fo patients Presse Medicale 30(15): 740-744
Nyasulu, J.C.Y.; Muchiri, E.; Mazwi, S.L.; Ratshefola, M. 2012: NIMART rollout to primary healthcare facilities increases access to antiretrovirals in Johannesburg: an interrupted time series analysis South African Medical Journal 103(4): 232-236
Fialová, P.; Vlcek, J. 2004: The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs Vnitrni Lekarstvi 50(11): 858-866
Forman, L. 2013: What contribution have human rights approaches made to reducing AIDS-related vulnerability in sub-Saharan Africa? Exploring the case study of access to antiretrovirals Global Health Promotion 20(1 Suppl): 57-63